David M. Spencer, Chief Technology Officer at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 40,000 shares at $7.63 ($305K) on 2018-07-18, disclosed to the SEC on 2018-07-20.
Seasonal sale ($305k) by Chief Technology Officer — this insider has traded BLCM in July in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| BLCM | SELL | 2016-12-05 | $100K | — | Filing → |
| BLCM | SELL | 2016-12-05 | $139K | — | Filing → |
| BLCM | SELL | 2016-09-23 | $453K | — | Filing → |